Cholesterol affects neuronal calcium signalling. A possible link between apolipoprotein polymorphism, β-amyloid neurotoxicity, and neurodegeneration in Alzheimer's disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 7, Issue 3, 1997, Pages 210-216

  Muller W E ^a   Hartmann, H ^a,b   Eckert, G P ^a   Eckert, A ^a   Eisert, S ^a  

^a Ctrl Institute of Mental Health J5   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Calcium signalling; Cholesterol; LDL

Indexed keywords

EID: 0013339678     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250: 279-282
2. Koh JY, Yang LL, Cotman CW (1990) β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 533: 315-320
3. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376-389
4. Hartmann H, Eckert A, Müller WE (1993) β-amyloid protein amplifies calcium signalling in central neurons from the adult mouse. Biochem Biophys Res Commun 193: 1216-1220
5. Eckert A, Hartmann H, Müller WE (1993) β-amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. FEBS Lett 330: 49-52
6. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325
7. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359: 325-328
8. Shoji M, Golde TE, Cheung TT, Ghiso J, Estus S, Shaffer LM, Cai XD, McKay DM, Tintner R, Frangione B, Youkin SG (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258: 126-129
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
10. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699
11. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630
12. Ignatius MJ, Gebicke-Haerter PJ, Skene JHP, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 83: 1125-1129
13. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haerter PJ, Ignatius MJ, Shooter EM (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83: 1015-1031
14. Dallongeville J, Lussier-Cacan S, Davignon J (1992) Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 33: 447-454
15. Vanhanen HT, Blomquist S, Ehnholm C, Hyvönen M, Jauhiainen M, Torstilla I, Miettinen TA (1993) Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 1535-1544
16. Pirttilä T, Soininen H, Heinonen O, Lehtimäki T, Bogdanovic N, Paljärvi L, Kosunen O, Winblad B, Riekkinen PS, Wisniewski HM, Mehta PD (1996) Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. Brain Res 722: 71-77
17. Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol Brain Res 33: 174-178
18. Mason RP, Shoemaker WJ, Shajenko L, Chambers TE, Herbette LG (1992) Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol. Neurobiol Aging 13: 413-419
19. Roth GS, Joseph JA, Mason RP (1995) Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. TINS 18: 203-206
20. Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 92: 12260-12264
21. Gleason MM, Medow MS, Tulenko TN (1991) Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ Res 69: 216-227
22. Mattson MP, Zhang Y, Bose S (1993) Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp Neurol 121: 1-13
23. Arispe N, Rojas E, Pollard HB (1993) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc Natl Acad Sci USA 90: 567-571
24. Chauhan A, Chauhan VPS, Brockerhoff H, Wisniewski HM (1993) Effect of amyloid β protein on membrane properties. In: Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P (eds) Alzheimer's disease: Advances in clinical and basic research. Wiley, pp 431-439
25. Mason RP, Estermyer JD, Kelly JF, Mason PE (1996) Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis. Biochem Biophys Res Commun 222: 78-82
26. Hartmann H, Eckert A, Müller WE (1994) Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to β-amyloid neurotoxicity. Biochem Biophys Res Commun 200: 1185-1192
27. Müller WE, Koch S, Eckert A, Hartmann H, Scheuer K (1995) β-amyloid peptide decreases membrane fluidity. Brain Res 674: 133-136
28. Müller WE, Eckert GP, Scheuer K, Maras A, Gattaz WF, Cairns N, Förstl H (1996) Effects of β-amyloid peptides on membrane fluidity in Alzheimer's disease. Soc Neurosc Abst 22: 2112
29. Johnson DA, Valenzuela CF, Zidovetzki R (1992) A deuterium nmr and steady-state fluorescence anisotropy study of the effects of cholesterol on the lipid membrane-disordered actions of ethanol. Biochem Pharmacol 44: 769-774
30. Chin JH, Goldstein DB (1981) Membrane-disordering action of ethanol: Variation with membrane cholesterol content and depth of the spin label probe. Mol Pharmacol 19: 425-431
31. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem 262: 14352-14360
32. Pitas RE (1997) Cerebrospinal fluid lipoproteins, lipoprotein receptors, and neurite outgrowth. Nutr Metab Cardiovasc Dis 7: 202-209
33. Block LH, Knorr M, Vogt E, Locher R, Vetter W, Groscurth P, Qiao B-Y, Pometta D, James R., Regenass M, Pletscher A (1988) Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci USA 85: 885-889
34. Bühler FR, Tkachuk VA, Hahn AWA, Resink TJ (1991) Low-and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J Hypertens 9: S28-S36
35. Schaefer HIMB, Höld KM, Egas-Kenniphaas JM, van der Laarse A (1993) Intracellular calcium signalling after binding of low-density lipoprotein to confluent and nonconfluent cultures of an endothelial cell line, EA.hy 926. Cell Calcium 14: 507-516
36. Bochkov VN, Tkachuk VA, Kuzmenko YS, Borisova YL, Bühler FR, Resink TJ (1994) Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol Pharmacol 45: 262-270
37. Chandler LJ, Crews FT (1990) Calcium- versus G-protein-mediated phosphoinositide hydrolysis in rat cerebral cortical synaptoneurosomes. J Neurochem 55: 1022-1030
38. Hartmann H, Müller WE (1993) Age-related changes in receptor-mediated and depolarization-induced phosphatidylinositol turnover in mouse brain. Brain Res 622: 86-92
39. Eisert S, Hartmann H, Müller WE (1995) Interaction of lipoproteins with neuronal calcium signalling. Pharmacopsychiatry 28: 175
40. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264: 850-852
41. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 92: 9480-9484
42. Hartmann H, Eckert A, Müller WE (1995) Apolipoprotein E (ApoE) fails to enhance the effect of β-amyloid on phospholipase C activity and on cellular calcium signalling. Soc Neurosci Abst 21: 1715
43. Kessler AR, Kessler B, Yehuda S (1985) Changes in the cholesterol level, cholesterol-to-phospholipid mole ratio, and membrane lipid microviscosity in rat brain induced by age and plant oil mixture. Biochem. Pharmacol. 34: 1120-1121
44. Maguire PA, Druse MJ (1989) The influence of cholesterol on synaptic fluidity and dopamine uptake. Brain Res Bull 22: 431-437
45. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 89: 1671-1675
46. Ginsberg L, Atack JR, Rapoport SI, Gershfeld NL (1993) Regional specificity of membrane instability in Alzheimer's disease brain. Brain Res. 615: 355-357
47. 2+ signalling in fully differentiated brain cells of adult mice. Amyloid: Int J Exp Clin Invest 3: 234-241